When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
SB 53 requires large AI labs – including OpenAI, Anthropic, Meta, and Google DeepMind – to be transparent about safety protocols. It also ensures whistleblower protections for employees at those companies.